Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-018428)

Filing Details

Accession Number:: 0001181431-11-018428
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-03-16 16:14:00
Reporting Period:: 2011-01-18

Filing Date:: 2011-03-16
Accepted Time:: 2011-03-16 16:14:00
Original Submission Date:: 2011-01-18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378586	Gautam Shah	C/O Achillion Pharmaceuticals 300 George Street New Haven CT 06511	Svp And Chief Compliance Ofc.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-18	4,000	$1.60	7,125	No	4	M	Direct
Common Stock	Acquisiton	2011-01-18	2,000	$1.60	9,125	No	4	M	Direct
Common Stock	Acquisiton	2011-01-18	5,000	$1.05	14,125	No	4	M	Direct
Common Stock	Acquisiton	2011-01-18	3,312	$3.28	17,437	No	4	M	Direct
Common Stock	Disposition	2011-01-18	14,312	$4.86	3,125	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Footnotes

These shares were unintentionally overstated on the reporting person's Form 4 filed on January 18, 2011.
The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $4.74 to $5.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.